Insulin secretion is decreased in non-diabetic individuals with hypomagnesaemia

Diabetes/Metabolism Research and Reviews

Volumn 27, Issue 6, 2011, Pages 590-596

  Rodríguez Morán, Martha ^a,b   Guerrero Romero, Fernando ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Research Group on Diabetes and Chronic Illnesses   (Mexico)

Author keywords

First phase of insulin secretion; Impaired fasting glucose; Impaired glucose tolerance; Insulin secretion; Magnesium; Second phase of insulin secretion

Indexed keywords

GLUCOSE; INSULIN; MAGNESIUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOMAGNESEMIA; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN RESISTANCE; MAGNESIUM; MALE; MIDDLE AGED;

EID: 80052599319     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1206     Document Type: Article

References (30)

1. Rosolova H, Mayer O, Jr, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Endocrinol Metab 1997; 82: 3783-3785.
2. Rumawas ME, McKeown NM, Rogers G, Meigs JB, Wilson PW, Jacques PF. Magnesium intake is related to improved insulin homeostasis in the Framingham offspring cohort. J Am Coll Nutr 2006; 25: 486-492.
3. Dzúrik R, Stefíková K, Spustová V, Fetkovská N. The role of magnesium deficiency in insulin resistance: an in vitro study. J Hypertens Suppl 1991; 9: S312-S313.
4. Hadjistavri LS, Sarafidis PA, Georgianos PI, et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit 2010; 16: CR307-CR312.
5. Kowluru A, Chen HQ, Modrick LM, Stefanelli C. Activation of acetyl-CoA carboxylase by a glutamate- and magnesium-sensitive protein phosphatase in the islet beta-cell. Diabetes 2001; 50: 1580-1587.
6. Matsunobu S, Terashima Y, Senshu T, Sano H, Itoh H. Insulin secretion and glucose uptake in hypomagnesemic sheep fed a low magnesium, high potassium diet. J Nutr Biochem 1990; 1: 167-171.
7. Curry DL, Joy RM, Holley DC, Bennett LL. Magnesium modulation of glucose-induced insulin secretion by the perfused rat pancreas. Endocrinology 1977; 101: 203-208.
8. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. Failure of β-cell function for compensate variation in insulin sensitivity in the hypomagnesemic subjects. Magnesium Res 2009; 22: 151-156.
9. Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 2004; 47: 943-956.
10. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999; 22 (Suppl. 1): S5-S19.
13. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
14. Palanivel R, Veluthakal R, McDonald P, Kowluru A. Further evidence for the regulation of acetyl-CoA carboxylase activity by a glutamate- and magnesium-activated protein phosphatase in the pancreatic beta cell: defective regulation in the diabetic GK rat islet. Endocrine 2005; 26: 71-77.
15. Murakami M, Ishizuka J, Sumi S, et al. Role of extracellular magnesium in insulin secretion from rat insulinoma cells. Proc Soc Exp Biol Med 1992; 200: 490-494.
16. Curry DL, Bennett LL. Magnesium requirement for somatostatin inhibition of insulin secretion. Acta Endocrinol (Copenh) 1984; 105: 83-86.
17. Paolisso G, Sgambato S, Gambardella A, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr 1992; 55: 1161-1167.
18. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid wall thickness: the ARIC study. J Clin Epidemiol 1985; 48: 927-940.
19. Rosolova H, Mayer O, Jr, Reaven GM. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasmaagnesium concentrations. Metabolism 2000; 49: 418-420.
20. Mooren FC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab 2011; 13: 281-284.
21. Guerrero-Romero F, Tamez-Perez HE, González-González G, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004; 30: 253-258.
22. Guerrero-Romero F, Rodríguez-Morán M. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res 2005; 36: 250-257.
23. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 2007; 458: 40-47.
24. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1999; 159: 2151-2159.
25. Paolisso G, Scheen A, D'Onofrio F, Lefèbvre P. Magnesium and glucose homeostasis. Diabetologia 1990; 33: 511-514.
26. Resnick LM. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of "syndrome X". Am J Hypertens 1993; 6: 123S-134S.
27. Rodriguez-Morán M, Guerrero-Romero F. Elevated concentrations of TNF-alpha are related to low serum magnesium levels in obese subjects. Magnes Res 2004; 17: 189-196.
28. Guerrero-Romero F, Rodríguez-Morán M. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res 2005; 36: 250-257.
29. Kahn C. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994; 43: 1066-1084.
30. Szoke E, Shrayyef MZ, Messing S, et al. Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care 2008; 31: 539-543.